Cape Bio Pharms is an exciting new (ad)venture based in Cape Town, South Africa. We are a spin-off company of the University of Cape Town aimed at commercialising the biotech developed by the Biopharming Research Unit (BRU) for the production of recombinant proteins in tobacco (actually a distant cousin of the tobacco plant).
Our product pipeline focuses on a wide range of research reagents such as antibodies, fusion proteins, peptides and enzymes. All are critical research tools for life scientists around the world in search of new drugs to treat the onslaught of human and animal diseases.
Our Custom Protein Service offers life scientists the opportunity of 'doing it in plants'. Plant-based expressions allows us to quickly and economically produce proof-of-concept trials from microgram to gram quantities. 'Doing it in plants' is an ethical alternative as we do not use animals in the making of our antibodies.
Our team is a passionate group of postgraduates from multiple disciplines such as Molecular & Cell Biology, Medical Biochemistry and Human and Cell Biology.
Our mission is to provide life-scientists with a wide range of quality, affordable and custom plant-made recombinant proteins they can trust to deliver guaranteed reproducible results.
Our world-class plant-based platform is the preferred expression system for the production of trusted, high quality recombinant proteins for biomedical research.